Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents…
The post New patent expiration for Boehringer Ingelheim drug SPIRI…
New patent expiration for Boehringer Ingelheim drug SPIRIVA Read Post »
Annual Drug Patent Expirations for VAZALORE Vazalore is a drug marketed by Plx Pharma and is included in one NDA. There are four patents protecting this drug. This drug has…
The post New patent expiration for Plx Pharma drug VAZALORE appeared first on …
New patent expiration for Plx Pharma drug VAZALORE Read Post »
FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications…
The post DrugPatent…
SPIRIVA (tiotropium bromide) Boehringer ingelheim Patent: 6,777,423 Expiration: Mar 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The po…
Drug Patent Expirations for the Week of March 20, 2022 Read Post »
Annual Drug Patent Expirations for VIMPAT Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent…
The post New patent expiration for Ucb Inc drug VIMPAT appeared first on DrugPatent…
VIMPAT (lacosamide) Ucb inc Patent: RE38551 Expiration: Mar 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expira…
Drug Patent Expirations for the Week of March 13, 2022 Read Post »
VIMPAT (lacosamide) Ucb inc Patent: RE38551 Expiration: Mar 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expira…
Drug Patent Expirations for the Week of March 13, 2022 Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for FUSILEV Fusilev is a drug marketed by Acrotech and is included in one NDA. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Acrotech drug FUSILEV appeared first on Drug…
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 7,223,440 Expiration: Mar 3, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …
Drug Patent Expirations for the Week of February 27, 2022 Read Post »